StockNews.com initiated coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Get Free Report) in a research report issued on Sunday. The firm set a “hold” rating on the stock.
TherapeuticsMD Trading Down 7.5 %
NASDAQ:TXMD opened at $1.61 on Friday. TherapeuticsMD has a 52 week low of $1.61 and a 52 week high of $4.35. The company has a fifty day moving average of $2.00 and a 200 day moving average of $2.18.
TherapeuticsMD (NASDAQ:TXMD – Get Free Report) last issued its quarterly earnings data on Friday, May 10th. The company reported ($0.07) EPS for the quarter. The business had revenue of $0.31 million for the quarter.
Institutional Inflows and Outflows
About TherapeuticsMD
TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.
Featured Articles
- Five stocks we like better than TherapeuticsMD
- Want to Profit on the Downtrend? Downtrends, Explained.
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Insider Selling Explained: Can it Inform Your Investing Choices?
- MarketBeat Week in Review – 6/24 – 6/28
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.